Literature DB >> 1481948

Abdominal vagal mediation of the satiety effects of exogenous and endogenous cholecystokinin in rats.

R D Reidelberger1.   

Abstract

The hypothesis that peripherally administered cholecystokinin C-terminal octapeptide (CCK-8) and endogenous CCK act by the same abdominal vagal mechanism to produce satiety was tested by injecting rats with CCK-8 or the type A CCK receptor antagonist MK-329 after they had received bilateral subdiaphragmatic vagotomies. CCK-8 (8 nmol/kg ip) inhibited 1-h food intake by 60%; vagotomy and MK-329 (0.5 mg/kg sc) each completely blocked this effect. In contrast, vagotomy did not alter the stimulatory effect of MK-329 (0.5 mg/kg sc) on feeding; 3-h cumulative intake in control and vagotomized animals was increased by 25 and 34%, respectively. These results suggest that satiety is mediated in part by an endogenous CCK action that is independent of abdominal vagal innervation.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1481948     DOI: 10.1152/ajpregu.1992.263.6.R1354

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  14 in total

1.  A peripheral mechanism for CB1 cannabinoid receptor-dependent modulation of feeding.

Authors:  Raquel Gómez; Miguel Navarro; Belén Ferrer; José M Trigo; Ainhoa Bilbao; Ignacio Del Arco; Andrea Cippitelli; Felice Nava; Daniele Piomelli; Fernando Rodríguez de Fonseca
Journal:  J Neurosci       Date:  2002-11-01       Impact factor: 6.167

Review 2.  Coming full circle: contributions of central and peripheral oxytocin actions to energy balance.

Authors:  Jacqueline M Ho; James E Blevins
Journal:  Endocrinology       Date:  2012-12-27       Impact factor: 4.736

3.  Synergistic interaction between leptin and cholecystokinin to reduce short-term food intake in lean mice.

Authors:  M D Barrachina; V Martínez; L Wang; J Y Wei; Y Taché
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-16       Impact factor: 11.205

4.  Sensitivity of vagal mucosal afferents to cholecystokinin and its role in afferent signal transduction in the rat.

Authors:  W Richards; K Hillsley; C Eastwood; D Grundy
Journal:  J Physiol       Date:  1996-12-01       Impact factor: 5.182

5.  Plasma cholecystokinin levels in Prader-Willi syndrome and obese subjects.

Authors:  M G Butler; M G Carlson; D E Schmidt; I D Feurer; T Thompson
Journal:  Am J Med Genet       Date:  2000-11-06

6.  Vanilloid, purinergic, and CCK receptors activate glutamate release on single neurons of the nucleus tractus solitarius centralis.

Authors:  Kirsteen N Browning; Shuxia Wan; Vander Baptista; R Alberto Travagli
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2011-05-04       Impact factor: 3.619

7.  Characterization of the role of endogenous cholecystokinin on the activity of the paraventricular nucleus of the hypothalamus in rats.

Authors:  Victoria Cano; Laura Ezquerra; M Pilar Ramos; Mariano Ruiz-Gayo
Journal:  Br J Pharmacol       Date:  2003-09-29       Impact factor: 8.739

8.  Normal feeding and body weight in Fischer 344 rats lacking the cholecystokinin-1 receptor gene.

Authors:  J E Blevins; J Overduin; J M Fuller; D E Cummings; K Matsumoto; D H Moralejo
Journal:  Brain Res       Date:  2008-12-16       Impact factor: 3.252

Review 9.  The role of hypothalamic estrogen receptors in metabolic regulation.

Authors:  Aaron Frank; Lynda M Brown; Deborah J Clegg
Journal:  Front Neuroendocrinol       Date:  2014-05-29       Impact factor: 8.606

10.  Characterization of the feeding inhibition and neural activation produced by dorsomedial hypothalamic cholecystokinin administration.

Authors:  J Chen; K A Scott; Z Zhao; T H Moran; S Bi
Journal:  Neuroscience       Date:  2008-03-03       Impact factor: 3.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.